LY3325656, CAS [[1998714-25-2]]

Artikelnummer: TGM-T70005
Artikelname: LY3325656, CAS [[1998714-25-2]]
Artikelnummer: TGM-T70005
Hersteller Artikelnummer: T70005
Alternativnummer: TGM-T70005-25MG,TGM-T70005-50MG,TGM-T70005-100MG
Hersteller: TargetMol
Kategorie: Biochemikalien
LY3325656 is a GPR142 agonist suitable for clinical testing in human. LY3325656 demonstrated anti-diabetic benefits in pre-clinical studies and ADME/PK properties suitable for human dosing. LY3325656 is the first GPR142 agonist molecule advancing to phase 1 clinic trials for the treatment of Type 2 diabetes.
Molekulargewicht: 448.44
CAS Nummer: [1998714-25-2]
Formel: C21H23F3N6O2
Target-Kategorie: Others
T70005